Skip to Content

Workers’ Compensation Board

Search menu

We are currently experiencing technical issues affecting some users' ability to access Board applications like eCase. In addition, users may also receive error messages within eCase. If you need assistance, or to report an issue, please email WCBCustomerSupport@wcb.ny.gov.


ECASE WILL BE UNAVAILABLE ON SUNDAY, MARCH 7, 2021 BETWEEN NOON AND 2PM

WCB Information Related to Novel Coronavirus (COVID-19)

Language Assistance: (877) 632-4996 |

Language Access Policy | Español | Русский | Polski | 中文 | Italiano | Kreyòl ayisyen | 한국어 | বাঙালি

Subject Number 046-1112 Board Announces Revised NYS Workers’ Compensation Drug Formulary Regulation

Board Bulletins and Subject Numbers

Date: October 17, 2018

The New York State Workers' Compensation Board (Board) has prepared a revision to the proposed NYS Workers' Compensation Drug Formulary (Formulary) announced in Subject Number 046-1012, Board Announces Draft Regulations for New York State Pharmacy Formulary on December 28, 2017. The proposed revision is in the October 17, 2018 State Register, and the Board will accept comments for 30 days. The revised proposed regulations are also available on the Board's website.

The Board substantially expanded the list of drugs on the Formulary, clarified the criteria for when certain drugs are on the Formulary and more fully defined the prior authorization process for drugs that are not listed on the Formulary.

The Board encourages the public, injured workers, employers, self-insured employers, insurance carriers, third-party administrators, attorneys, medical providers, and labor and business organizations to provide comment. Please submit your comments on or before November 16, 2018, to regulations@wcb.ny.gov. The Board will evaluate all comments received and will consider necessary revisions as the process advances.

The Board is committed to the successful implementation of the Formulary.

We look forward to receiving your comments.

Clarissa M. Rodriguez
Chair